Sodium channel protein type 8 subunit alpha
Also known as: MED, SCN8A
Function
Pore-forming subunit of a voltage-gated sodium channel complex assuming opened or closed conformations in response to the voltage difference across membranes and through which sodium ions selectively pass along their electrochemical gradient. Contributes to neuronal excitability by regulating action potential threshold and propagation.
Classification
- Family (Pfam)
- PF00520 Ion_trans, PF24609 IQ_SCN5A_C, PF06512 Na_trans_assoc, PF11933 Na_trans_cytopl
- InterPro
- Ion_trans_dom, IQ_motif_EF-hand-BS, IQ_SCN5A_C, Na_channel_a8su, Na_channel_asu, Na_chnl_inactivation_gate, Na_trans_assoc_dom, Na_trans_cytopl, VGCC_Ca_Na, Volt_channel_dom_sf
- Functional cluster
- DEAD-Box RNA Helicases & Biogenesis Factors
Experimental structures · PDB · 4
A predicted model is available from AlphaFold.
Gene Ontology · 18
- GO:0030424 axon
- GO:0043194 axon initial segment
- GO:0031410 cytoplasmic vesicle
- GO:0016020 membrane
- GO:0033268 node of Ranvier
- GO:0005886 plasma membrane
- GO:0002102 podosome
- GO:0001518 voltage-gated sodium channel complex
- GO:0030018 Z disc
- GO:0031402 sodium ion binding
- GO:0005248 voltage-gated sodium channel activity
- GO:0001508 action potential
- GO:0086002 cardiac muscle cell action potential involved in contraction
- GO:0086010 membrane depolarization during action potential
- GO:0042552 myelination
- GO:0007422 peripheral nervous system development
- GO:0035725 sodium ion transmembrane transport
- GO:0006814 sodium ion transport
Disease associations
- cognitive impairment with or without cerebellar ataxia MONDO:0013680
- developmental and epileptic encephalopathy, 13 MONDO:0013801
- seizures, benign familial infantile, 5 MONDO:0014903
- myoclonus, familial, 2 MONDO:0100092
Drugs targeting this protein · 56
- OXCARBAZEPINE blocker
- CARBAMAZEPINE blocker
- ETHOTOIN blocker
- PRILOCAINE blocker
- MORICIZINE HYDROCHLORIDE blocker
- INDECAINIDE HYDROCHLORIDE blocker
- ORPHENADRINE CITRATE blocker
- LIDOCAINE HYDROCHLORIDE blocker
- QUINIDINE GLUCONATE blocker
- MEPIVACAINE HYDROCHLORIDE blocker
- PROPARACAINE HYDROCHLORIDE blocker
- DYCLONINE HYDROCHLORIDE blocker
- PRILOCAINE HYDROCHLORIDE blocker
- ETIDOCAINE HYDROCHLORIDE blocker
- MEXILETINE HYDROCHLORIDE blocker
- BENOXINATE HYDROCHLORIDE blocker
- HEXYLCAINE HYDROCHLORIDE blocker
- TOCAINIDE HYDROCHLORIDE blocker
- ARTICAINE HYDROCHLORIDE blocker
- PROCAINE HYDROCHLORIDE blocker
- DISOPYRAMIDE PHOSPHATE blocker
- PHENAZOPYRIDINE HYDROCHLORIDE blocker
- ORPHENADRINE HYDROCHLORIDE blocker
- PROPAFENONE HYDROCHLORIDE blocker
- DRONEDARONE HYDROCHLORIDE blocker
- RUFINAMIDE blocker
- TETRACAINE HYDROCHLORIDE blocker
- PHENYTOIN blocker
- PHENYTOIN SODIUM blocker
- PROPOXYCAINE HYDROCHLORIDE blocker
- ROPIVACAINE HYDROCHLORIDE blocker
- ENCAINIDE HYDROCHLORIDE blocker
- NERISPIRDINE blocker
- RALFINAMIDE blocker
- TOPIRAMATE blocker
- IRAMPANEL blocker
- ESLICARBAZEPINE blocker
- DICHLOROBENZYL ALCOHOL blocker
- EVENAMIDE blocker
- QUINIDINE SULFATE blocker
- CENOBAMATE inhibitor
- ZANDATRIGINE inhibitor
- COCAINE HYDROCHLORIDE blocker
- LACOSAMIDE blocker
- PROCAINAMIDE HYDROCHLORIDE blocker
- TETRACAINE blocker
- LAMOTRIGINE blocker
- RILUZOLE blocker
- ZONISAMIDE blocker
- LIDOCAINE blocker
- PRIMIDONE blocker
- MEPHENYTOIN blocker
- ESLICARBAZEPINE ACETATE blocker
- PHENACEMIDE blocker
- FOSPHENYTOIN SODIUM blocker
- CHLOROPROCAINE HYDROCHLORIDE blocker
Neighborhood · nearest proteins
Related proteins · sequence + function similarity
- Sodium channel protein type 8 subunit alpha 1.00
- Sodium channel protein type 8 subunit alpha 1.00
- Sodium channel protein type 9 subunit alpha 0.99
- Sodium channel protein type 2 subunit alpha 0.99
- Sodium channel protein type 2 subunit alpha 0.99
- Sodium channel protein type 9 subunit alpha 0.98
- Sodium channel protein type 3 subunit alpha 0.98
- Sodium channel protein type 2 subunit alpha 0.98
- Sodium channel protein type 3 subunit alpha 0.98
- Sodium channel protein type 9 subunit alpha 0.98
- Sodium channel protein type 3 subunit alpha 0.98
- Sodium channel protein type 9 subunit alpha 0.98
Co-cited proteins · studied together in the literature
- Sodium channel protein type 8 subunit alpha 4 shared papers
- Fibroblast growth factor 13 3 shared papers
- Protein unc-13 homolog C 1 shared papers
- Sodium channel protein type 8 subunit alpha 2 shared papers
- Sodium channel regulatory subunit beta-1 3 shared papers
- E3 ubiquitin-protein ligase RING1 1 shared papers
- Sodium channel regulatory subunit beta-2 1 shared papers
- Neuropilin-2 1 shared papers
- Chromodomain Y-like protein 1 shared papers
- Beta/delta-theraphotoxin-Pre1a 1 shared papers
- Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 1 shared papers
- Fibroblast growth factor 14 1 shared papers
Literature · 30 cited papers
- Pain-causing stinging nettle toxins target TMEM233 to modulate NaV1.7 function. Nat. Commun. · 2023
- Structure of human NaV1.6 channel reveals Na+ selectivity and pore blockade by 4,9-anhydro-tetrodotoxin. Nat. Commun. · 2023
- Cryo-EM structure of human voltage-gated sodium channel Nav1.6. Proc. Natl. Acad. Sci. U.S.A. · 2023
- Missense variants in the N-terminal domain of the A isoform of FHF2/FGF13 cause an X-linked developmental and epileptic encephalopathy. Am. J. Hum. Genet. · 2021
- Partial loss-of-function of sodium channel SCN8A in familial isolated myoclonus. Hum. Mutat. · 2018
- SCN8A mutations in Chinese patients with early onset epileptic encephalopathy and benign infantile seizures. BMC Med. Genet. · 2017
- CDYL suppresses epileptogenesis in mice through repression of axonal Nav1.6 sodium channel expression. Nat. Commun. · 2017
- The tarantula toxin beta/delta-TRTX-Pre1a highlights the importance of the S1-S2 voltage-sensor region for sodium channel subtype selectivity. Sci. Rep. · 2017
- Diagnostic targeted resequencing in 349 patients with drug-resistant pediatric epilepsies identifies causative mutations in 30 different genes. Hum. Mutat. · 2017
- Autosomal dominant SCN8A mutation with an unusually mild phenotype. Eur. J. Paediatr. Neurol. · 2016
- Improving diagnosis and broadening the phenotypes in early-onset seizure and severe developmental delay disorders through gene panel analysis. J. Med. Genet. · 2016
- Pathogenic mechanism of recurrent mutations of SCN8A in epileptic encephalopathy. Ann. Clin. Transl. Neurol. · 2016
- … and 18 more in the literature graph
A document in the lmmol reference corpus — open public data (UniProt, GO, PDB, the literature graph) rendered as a single cross-linked page. Hover any link to preview its target.